Countable Labs

Countable Labs is a private, commercial-stage company offering a breakthrough PCR platform that directly counts individual DNA molecules with high precision. Its Countable PCR technology claims significant advantages over existing methods, including 10x better sensitivity than dPCR, automated real-time analysis, and simplified multiplex assay development. The company has achieved CE marking for its Countable 4 system, indicating initial regulatory approval for the European market and validation from key opinion leaders in clinical diagnostics, rare event detection, and cell & gene therapy.

Countable PCR: A nucleic acid quantification platform that uses ~30 million compartments per reaction to physically isolate and directly count single DNA molecules via a laser-based multi-color optical system, enabling true absolute quantification without Poisson statistics.

Countable PCR directly competes with established quantitative PCR (qPCR) systems from companies like Thermo Fisher, Bio-Rad, and Roche, and digital PCR (dPCR) systems from Bio-Rad (ddPCR) and Thermo Fisher (QuantStudio). Its key differentiators are claimed superior sensitivity (10x better than dPCR), higher precision, easier multiplexing, and automated analysis, positioning it as a potential best-in-class solution for absolute quantification.